Evaluation of Efficacy and Safety of Topical 1% Medroxyprogesterone in the Corneal Epithelium Healing After PRK

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

April 21, 2023

Primary Completion Date

June 21, 2023

Study Completion Date

July 6, 2023

Conditions
Photorefractive Keratectomy
Interventions
DRUG

prepared drop of medroxy progestrone acetat 1%

In 37 patients who are candidates for photorefractive keratectomy, at the end of the procedure, in one eye randomly, in addition to the antibiotic drop that is routinely placed at the end of the procedure, a drop of prepared medroxyprogesterone is also placed. Then, a bandage contact lens is placed on the eyes, and the patient receives the routine post-procedure drops that include betamethasone and ciprofloxacin drops for both eyes.

Trial Locations (2)

0098

Isfahan eyes research centre, Isfahan

81746-73461

Isfahan Eye Research Center, Isfahan

All Listed Sponsors
collaborator

Isfahan Ophthalmology Research Center

NETWORK

lead

Isfahan University of Medical Sciences

OTHER